Interstitial pneumonia pattern on day 7 chest radiograph predicts bronchopulmonary dysplasia in preterm infants

Hye-Rim Kim1,2,3, Ji Young Kim4, Bo La Yun4

  • 1Department of Pediatrics, Bundang CHA Medical Center, CHA University, Seongnam, Republic of Korea.

BMC Pediatrics
|May 17, 2017
PubMed

Insights

Early chest X-rays showing interstitial pneumonia in preterm infants can identify those at high risk for bronchopulmonary dysplasia (BPD) or death. This allows for targeted interventions to improve outcomes for vulnerable newborns.

Area of Science:

  • Neonatology
  • Pediatric Radiology
  • Respiratory Medicine

Background:

  • Bronchopulmonary dysplasia (BPD) is a significant complication in preterm infants.
  • Early identification of infants at risk for BPD is crucial for timely intervention.
  • Current methods for risk stratification may not be sufficiently precise.

Purpose of the Study:

  • To evaluate if the interstitial pneumonia pattern on day 7 chest radiographs predicts BPD or death before 36 weeks postmenstrual age (PMA).
  • To assess the utility of early radiographic findings in identifying high-risk preterm infants.

Main Methods:

  • Retrospective cohort study of 336 preterm infants (birth weight < 1500g, GA < 32 weeks).
  • Day 7 chest radiographs reviewed by two independent pediatric radiologists.
  • Analysis of data from 304 infants surviving > 7 days.

Main Results:

  • Interstitial pneumonia pattern on day 7 chest radiograph was associated with BPD or death before 36 weeks PMA (OR 4.0).
  • This pattern demonstrated high specificity (98%) in predicting BPD or death.
  • Histologic chorioamnionitis was a preceding factor associated with the interstitial pneumonia pattern (OR 3.7).

Conclusions:

  • The interstitial pneumonia pattern on day 7 chest radiographs is a specific predictor of BPD or death in preterm infants.
  • This finding can guide the selection of high-risk infants for preventive interventions.
  • Early radiographic assessment aids in targeted management strategies for BPD.
Abstract

Related Concept Videos

Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
1.2K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.1K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.6K
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
4.3K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.0K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
944